**Meet the editor**

Dr. Lasfar is a professor at Rutgers University, New Jersey. He is also editor and board member of several international journals and books. Dr. Lasfar is a scientific adviser to the pharmaceutical industry and a member of several medical and scientific societies. He is also head of the NIH-funded laboratory at Rutgers University, focused on cancer immunotherapy. Dr. Lasfar graduated

in Medical and Applied Science from Paris Rene Descartes University in France. He completed his doctoral studies in Immunology at Paris Diderot University and his postdoctoral training in Cancer Immunology at Robert Wood Johnson Medical School, New Jersey.

Contents

**Preface VII**

**Therapies 3** Ahmed Lasfar

**Liver Disease 13** Mark A. Feitelson

Chapter 1 **Introductory Chapter: Liver Cancer, Risk Factors and Current**

Chapter 3 **HCC in Elderly Patients. Curative Intraoperative Strategies and**

Kevin Labadie, Kevin M. Sullivan and James O. Park

Vasileia Ntomi, Anna Paspala and Dimitrios Schizas

Stefania Brozzetti, Simone Bini, Leonardo Luca Chiarella, Katia

**Section 2 Liver Pathogenesis and Cancer Development 11**

**Management in Recurrences 33**

**Section 3 Surgical Resection of Liver Cancer 57**

Chapter 4 **Surgical Resection in HCC 59**

Fazzi, Michele Di Martino and Mario Bezzi

Chapter 5 **Novel Techniques in the Surgical Management of**

**Hepatocellular Carcinoma 77**

Chapter 2 **Pathogenesis of Hepatitis B Virus Associated Chronic**

**Section 1 Introduction 1**
